T. Hévor

发表

Epilepsy, Regulation of Brain Energy Metabolism and Neurotransmission

J. Cloix, T. Hévor, 2009, Current medicinal chemistry.

Direct cloning of astrocytes from primary culture without previous immortalization

T. Hévor, O. Mbarek, V. Vergé, 1998, In Vitro Cellular & Developmental Biology - Animal.

A fraction of neurofibromin interacts with PML bodies in the nucleus of the CCF astrocytoma cell line.

C. Pichon, S. Villette, T. Hévor, 2012, Biochemical and biophysical research communications.

Chronic inhibition of glutamine synthetase is not associated with impairment of learning and memory in mice

Wim E Crusio, J. Cloix, T. Hévor, 2002, Brain Research Bulletin.

Selection of two lines of mice based on latency to onset of methionine sulfoximine seizures

J. Cloix, T. Hévor, Zahir Tahi, 2010, Epilepsia.

Biochemical and ultrastructural study of glycogen in cultured astrocytes submitted to the convulsant methionine sulfoximine

T. Hévor, P. Delorme, 1991, Glia.

Abnormal organelles in cultured astrocytes are largely enhanced by streptomycin and intensively by gentamicin

T. Hévor, F. Robert, 2007, Neuroscience.

Some aspects of carbohydrate metabolism in the brain.

T. Hévor, 1994, Biochimie.

Early, middle, and late stages of neural cells from ovine embryo in primary cultures

T. Hévor, A. Duittoz, O. Richard, 1998, Neuroscience Research.

Isolation of carbohydrate metabolic clones from cultured astrocytes

A. Legrand, T. Hévor, V. Vergé, 1996, Glia.

Stimulation of Fructose‐1,6‐Biphosphatase Activity and Synthesis in the Cerebral Cortex of Rats Submitted to the Convulsant Methionine Sulfoximine

T. Hévor, J. Gayet, 1981, Journal of neurochemistry.

Correlation between brain glycogen and convulsive state in mice submitted to methionine sulfoximine.

E. Lapouble, J. Cloix, T. Hévor, 2000, Life sciences.

Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes.

M. Saboungi, J. Salvetat, S. Bhattacharyya, 2009, Toxicology in vitro : an international journal published in association with BIBRA.

Amphetamine-induced changes in body temperature and glycogen content of the encephalon in the chicken

T. Hévor, J. Gayet, P. Lehr, 1975, Experientia.

Glycogen as a Putative Target for Diagnosis and Therapy in Brain Pathologies

J. Cloix, T. Hévor, 2011 .

A new putative target for antisense gene therapy of glioma: Glycogen synthase

J. Trojan., H. Duc, J. Cloix, 2007, Cancer biology & therapy.

Monoamines and glycogen levels in cerebral cortices of fast and slow methionine sulfoximine-inbred mice

L. Landemarre, J. Cloix, T. Hévor, 2013, Epilepsy Research.

Correlation between carbohydrate and catecholamine level impairments in methionine sulfoximine epileptogenic rat brain

T. Hévor, P. Delorme, E. Aissi, 1990, Neurochemical Research.

Necrotic cell death induced by δ‐aminolevulinic acid in mouse astrocytes. Protective role of melatonin and other antioxidants

M. Kotler, T. Hévor, A. Quaglino, 2003, Journal of pineal research.

The xenobiotic methionine sulfoximine modulates carbohydrate anabolism and related genes expression in rodent brain.

J. Cloix, T. Hévor, M. Ardourel, 2000, Toxicology.

Ultrastructural characterization of rat neurons in primary culture

J. Cloix, T. Hévor, F. Robert, 2012, Neuroscience.

Primary culture of neural precursors from the ovine central nervous system (CNS)

T. Hévor, A. Duittoz, 2001, Journal of Neuroscience Methods.

GLYCOGEN CONTENT AND FRUCTOSE‐1, 6‐BIPHOSPHATASE ACTIVITY IN METHIONINE SULFOXIMINE EPILEPTOGENIC MOUSE BRAIN AND LIVER AFTER PROTEIN SYNTHESIS INHIBITION

T. Hévor, J. Gayet, P. Delorme, 1985, Neuropathology and applied neurobiology.

Cyclic nucleotides in the brain of mice and rats submitted to the convulsant, methionine sulfoximine.

T. Hévor, J. Gayet, 1979, Biochemical pharmacology.

Serotonergic neurotransmission plays a major role in the action of the glycogenic convulsant methionine sulfoximine

J. Cloix, T. Hévor, M. Picard, 2011, Neuroscience Research.

Stable transfection of cDNAs targeting specific steps of glycogen metabolism supports the existence of active gluconeogenesis in mouse cultured astrocytes

P. Magistretti, J. Cloix, T. Hévor, 2002, Glia.

Fructose-1,6-biphosphatase and phosphofructokinase activities in the brain of mice submitted to methionine sulfoximine

T. Hévor, J. Gayet, 1978, Brain Research.

Phenotypic differences between fast and slow methionine sulfoximine-inbred mice: Seizures, anxiety, and glutamine synthetase

J. Cloix, T. Hévor, Arnaud Boissonnet, 2012, Epilepsy Research.

In vivo and in vitro glycogenic effects of methionine sulfoximine are different in two inbred strains of mice

J. Cloix, T. Hévor, K. Bernard-Hélary, 2002, Brain Research.

Pharmacological, neurochemical, and behavioral profile of JB-788, a new 5-HT1A agonist

J. Bizot, J. Cloix, T. Hévor, 2010, Neuroscience.

Methionine sulfoximine induces a decrease in the tryptophan level of mouse brain

T. Hévor, M. Guérin, M. Picard, 2006 .

Uptake of functionalized mesoporous silica nanoparticles by human cancer cells.

Gerald Lelong, M. Saboungi, J. Salvetat, 2010, Journal of nanoscience and nanotechnology.

Catecholamine and indoleamine levels in chick cultured neurons and embryonic brain

T. Hévor, F. Bernet, P. Delorme, 1988, Neurochemical Research.

Glycogen Synthesis and Immunocytochemical Study of Fructose-1,6-Biphosphatase in Methionine Sulfoximine Epileptogenic Rodent Brain

J. Beauvillain, T. Hévor, P. Delorme, 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Brain glycogen and neurotransmitter levels in fast and slow methionine sulfoximine-selected mice

J. Cloix, T. Hévor, Zahir Tahi, 2010, Experimental Neurology.

Various fructose‐1,6‐ bisphosphatase mRNAs in mouse brain, liver, kidney and heart

J. Cloix, T. Hévor, Emmanuelle Beaulieu, 1997, Neuroreport.

GLYCOGEN PARTICLES IN METHIONINE SULFOXIMINE EPILEPTOGENIC RODENT BRAIN AND LIVER AFTER THE ADMINISTRATION OF METHIONINE AND ACTINOMYCIN D

T. Hévor, P. Delorme, T. K. HEVOR, 1985, Neuropathology and applied neurobiology.